Gse1-KO Mouse
一般名
Gse1-KO
製品ID
S-KO-09839
背景情報
C57BL/6NCya
系統ID
KOCMP-382034-Gse1-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Gse1-KO Mouse(カタログ番号S-KO-09839)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Gse1-KO
系統ID
KOCMP-382034-Gse1-B6N-VA
遺伝子名
製品ID
S-KO-09839
遺伝子別名
mKIAA0182, 2210013I18Rik
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000034279
NCBIトランスクリプトID
NM_198671
ターゲット領域
Exon 4~13
有効領域の大きさ
~8.9 kb
遺伝子研究の概要
GSE1, also known as KIAA0182, is a proline-rich protein. It is a component of the CoREST complex, which acts as an H3K4 and H3K9 demethylase and regulates gene expression. GSE1 is involved in the DNA damage response (DDR) pathway, as it forms a complex with the HDAC1/CoREST deacetylase/demethylase co-repressor complex and plays a role in histone modification and DNA damage sensing during DDR [1].
Gse1 has been studied using gene knockout models. Maternal or zygotic deletion of Gse1 in mice leads to prenatal death, embryonic lethality from E12.5, and perinatal death, indicating its essential role in mouse development, especially in placenta development [2]. In cancer research, loss-of-function experiments in various cancer cell lines have shown that depletion of GSE1 inhibits the proliferation, migration, and invasion of lung adenocarcinoma, breast cancer, gastric cancer, and castration-resistant prostate cancer cells [3,4,5,7]. In AML, pharmacological inhibition of LSD1 downregulates GSE1, leading to myeloid differentiation [6].
In conclusion, GSE1 is crucial for normal development, especially placenta development in mice. In disease, particularly in cancer, GSE1 often acts as an oncogene promoting cancer cell growth, migration, and resistance to therapies. Gene knockout and related functional studies of GSE1 in mouse models and cell lines have provided valuable insights into its role in normal biological processes and disease conditions, potentially guiding the development of new cancer therapies.
References:
1. Vcelkova, Terezia, Reiter, Wolfgang, Zylka, Martha, Hartl, Markus, Seiser, Christian. . GSE1 links the HDAC1/CoREST co-repressor complex to DNA damage. In Nucleic acids research, 51, 11748-11769. doi:10.1093/nar/gkad911. https://pubmed.ncbi.nlm.nih.gov/37878419/
2. Hiver, Sylvain, Shimizu-Mizuno, Natsumi, Ikawa, Yayoi, Tanaka, Satoshi, Hamada, Hiroshi. 2023. Gse1, a component of the CoREST complex, is required for placenta development in the mouse. In Developmental biology, 498, 97-105. doi:10.1016/j.ydbio.2023.03.009. https://pubmed.ncbi.nlm.nih.gov/37019373/
3. Meng, Ziyu, Yang, Yingqian, Li, Shupei, Wang, Wenbin, Wang, Fengsong. 2024. GSE1 promotes the proliferation and migration of lung adenocarcinoma cells by downregulating KLF6 expression. In Cell biology international, 48, 1490-1506. doi:10.1002/cbin.12208. https://pubmed.ncbi.nlm.nih.gov/38886911/
4. Chai, Peng, Tian, Jingzhong, Zhao, Deyin, Ding, Keshuo, Liu, Bin. 2016. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion. In Biochemical and biophysical research communications, 471, 123-8. doi:10.1016/j.bbrc.2016.01.168. https://pubmed.ncbi.nlm.nih.gov/26828271/
5. Ding, Keshuo, Tan, Sheng, Huang, Xing, Wang, Wenbin, Wu, Zhengsheng. 2018. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. In The Journal of biological chemistry, 293, 3949-3964. doi:10.1074/jbc.RA117.001103. https://pubmed.ncbi.nlm.nih.gov/29367342/
6. Nicosia, Luciano, Boffo, Francesca Ludovica, Ceccacci, Elena, Minucci, Saverio, Bonaldi, Tiziana. 2021. Pharmacological inhibition of LSD1 triggers myeloid differentiation by targeting GSE1 oncogenic functions in AML. In Oncogene, 41, 878-894. doi:10.1038/s41388-021-02123-7. https://pubmed.ncbi.nlm.nih.gov/34862459/
7. Bamodu, Oluwaseun Adebayo, Wang, Yuan-Hung, Ho, Chen-Hsun, Chen, Kuan-Chou, Wu, Chia-Chang. 2021. Genetic Suppressor Element 1 (GSE1) Promotes the Oncogenic and Recurrent Phenotypes of Castration-Resistant Prostate Cancer by Targeting Tumor-Associated Calcium Signal Transducer 2 (TACSTD2). In Cancers, 13, . doi:10.3390/cancers13163959. https://pubmed.ncbi.nlm.nih.gov/34439112/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
